Jubilant Life Sciences, a prominent player in the pharmaceutical and life sciences sector, is headquartered in Noida, India. Founded in 1978, the company has established a strong presence in key operational regions, including North America, Europe, and Asia. Specialising in contract manufacturing, active pharmaceutical ingredients (APIs), and drug delivery solutions, Jubilant Life Sciences is recognised for its commitment to quality and innovation. The company’s core offerings, which include a diverse range of generic pharmaceuticals and specialty chemicals, set it apart in a competitive market. With a focus on sustainability and advanced technology, Jubilant Life Sciences has achieved significant milestones, including multiple regulatory approvals and partnerships with leading global firms. This positions the company as a trusted partner in the healthcare industry, dedicated to improving patient outcomes worldwide.
How does Jubilant Life Sciences's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Jubilant Life Sciences's score of 43 is higher than 66% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, Jubilant Life Sciences reported total carbon emissions of approximately 8620000 kg CO2e for Scope 1, 68152000 kg CO2e for Scope 2, and 737234000 kg CO2e for Scope 3, resulting in a combined total of about 76772000 kg CO2e for Scope 1 and 2. This reflects a slight increase in emissions compared to 2023, where Scope 1 emissions were about 8492000 kg CO2e, Scope 2 emissions were 54703000 kg CO2e, and Scope 3 emissions were 662296000 kg CO2e, leading to a total of approximately 63195000 kg CO2e for Scope 1 and 2. Jubilant Life Sciences has set ambitious climate commitments, aiming for net zero emissions by 2050 for both Scope 1 and Scope 2 emissions. This long-term target was established in 2023, indicating a proactive approach to reducing their carbon footprint. The company is currently on track to meet its five-year goals, demonstrating a commitment to sustainability and climate responsibility. The emissions data is not cascaded from any parent organization, and all figures are reported directly from Jubilant Life Sciences. The company continues to monitor and report its emissions across all scopes, ensuring transparency and accountability in its climate initiatives.
Access structured emissions data, company-specific emission factors, and source documents
2013 | 2015 | 2016 | 2017 | 2019 | 2020 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|---|---|
Scope 1 | 894,456,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 0,000,000 | 0,000,000 |
Scope 2 | 107,906,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
Scope 3 | 12,057,000 | - | - | - | 00,000,000 | 00,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Jubilant Life Sciences is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.